Skip to main content

Table 1 Demographics and baseline characteristics of the Canadian subgroup in all three trials

From: The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children

 

2009 studies

2012 study

 

Adults

Children

Adults + children*

Characteristic

Placebo(n=33)

Grass SLIT-T(n=24)

Placebo(n=23)

Grass SLIT-T(n=23)

Placebo(n=141)

Grass SLIT-T(n=142)

Male, %

45

46

57

61

59

49

Age, mean y

35.6

32.8

12.4

11.0

35.7

33.6

White, %

82

92

91

87

81

85

Asthma, %

36

25

17

17

21

25

Polysensitized, %

88

96

91

74

89

89

  1. *The 2012 study involved 262 adults and 21 children.
Back to article page

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us